Healthcare -
Biotechnology - NASDAQ - IL
$ 3.4
-4.76 %
$ 14.8 M
Market Cap
-0.28
P/E
BLRX - COST OF REVENUE
Cost of Revenue BLRX - BioLineRx Ltd.
3.69 M
LAST VALUE
129.33%
2 YEAR CAGR
52.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR